当前位置: X-MOL 学术Mucosal Immunol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The IL-33-ILC2 pathway protects from amebic colitis
Mucosal Immunology ( IF 7.9 ) Pub Date : 2021-08-16 , DOI: 10.1038/s41385-021-00442-2
Md Jashim Uddin 1, 2 , Jhansi L Leslie 1 , Stacey L Burgess 1 , Noah Oakland 1 , Brandon Thompson 3 , Mayuresh Abhyankar 1 , Julio Revilla 1 , Alyse Frisbee 3 , Alexandra N Donlan 3 , Pankaj Kumar 4 , William A Petri 1, 2, 3
Affiliation  

Entamoeba histolytica is a pathogenic protozoan parasite that causes intestinal colitis, diarrhea, and in some cases, liver abscess. Through transcriptomics analysis, we observed that E. histolytica infection was associated with increased expression of IL-33 mRNA in both the human and murine colon. IL-33, the IL-1 family cytokine, is released after cell injury to alert the immune system of tissue damage. Treatment with recombinant IL-33 protected mice from amebic infection and intestinal tissue damage; moreover, blocking IL-33 signaling made mice more susceptible to amebiasis. IL-33 limited the recruitment of inflammatory immune cells and decreased the pro-inflammatory cytokine IL-6 in the cecum. Type 2 immune responses were upregulated by IL-33 treatment during amebic infection. Interestingly, administration of IL-33 protected RAG2/– mice but not RAG2−/−γc−/− mice, demonstrating that IL-33-mediated protection required the presence of innate lymphoid cells (ILCs). IL-33 induced recruitment of ILC2 but not ILC1 and ILC3 in RAG2−/− mice. At baseline and after amebic infection, there was a significantly higher IL13+ILC2s in C57BL/J mice, which are naturally resistant to amebiasis, than CBA/J mice. Adoptive transfer of ILC2s to RAG2−/−γc−/− mice restored IL-33-mediated protection. These data reveal that the IL-33-ILC2 pathway is an important host defense mechanism against amebic colitis.



中文翻译:

IL-33-ILC2 通路可预防阿米巴结肠炎

溶组织内阿米巴是一种致病性原生动物寄生虫,可引起肠结肠炎、腹泻,在某些情况下还会引起肝脓肿。通过转录组学分析,我们观察到E. histolytica感染与人和小鼠结肠中 IL-33 mRNA 的表达增加有关。IL-33 是 IL-1 家族细胞因子,在细胞损伤后释放,以提醒免疫系统注意组织损伤。用重组 IL-33 治疗可保护小鼠免受阿米巴感染和肠组织损伤;此外,阻断 IL-33 信号使小鼠更容易感染阿米巴病。IL-33 限制了炎症免疫细胞的募集并减少了盲肠中的促炎细胞因子 IL-6。2 型免疫反应在阿米巴感染期间被 IL-33 治疗上调。有趣的是,给予 IL-33 可保护 RAG2 /–小鼠,但不能保护 RAG2 −/− γc −/−小鼠,证明 IL-33 介导的保护需要先天淋巴样细胞 (ILC) 的存在。IL-33 在 RAG2 -/-小鼠中诱导 ILC2 而非 ILC1 和 ILC3 的募集。在基线和阿米巴感染后,天然抗阿米巴病的 C57BL/J 小鼠中的 IL13+ILC2s 显着高于 CBA/J 小鼠。将 ILC2 过继转移至 RAG2 -/- γc -/-小鼠可恢复 IL-33 介导的保护作用。这些数据表明 IL-33-ILC2 通路是宿主对抗阿米巴结肠炎的重要防御机制。

更新日期:2021-08-16
down
wechat
bug